Fidelity Investments’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$83.9M Sell
1,718,287
-295,275
-15% -$14.4M ﹤0.01% 1192
2025
Q1
$103M Buy
2,013,562
+1,193,518
+146% +$60.8M 0.01% 1085
2024
Q4
$37M Sell
820,044
-237,138
-22% -$10.7M ﹤0.01% 1503
2024
Q3
$39.2M Sell
1,057,182
-46,917
-4% -$1.74M ﹤0.01% 1472
2024
Q2
$33.8M Sell
1,104,099
-622,963
-36% -$19.1M ﹤0.01% 1465
2024
Q1
$50.2M Sell
1,727,062
-87,359
-5% -$2.54M ﹤0.01% 1328
2023
Q4
$50M Sell
1,814,421
-6,650,963
-79% -$183M ﹤0.01% 1291
2023
Q3
$190M Sell
8,465,384
-1,787,740
-17% -$40.1M 0.02% 721
2023
Q2
$417M Buy
10,253,124
+669,956
+7% +$27.2M 0.04% 467
2023
Q1
$464M Sell
9,583,168
-1,199,138
-11% -$58.1M 0.04% 435
2022
Q4
$412M Buy
10,782,306
+51,162
+0.5% +$1.95M 0.04% 460
2022
Q3
$539M Buy
10,731,144
+30,307
+0.3% +$1.52M 0.06% 331
2022
Q2
$429M Sell
10,700,837
-26,308
-0.2% -$1.05M 0.04% 420
2022
Q1
$400M Buy
10,727,145
+122,460
+1% +$4.57M 0.03% 514
2021
Q4
$422M Buy
10,604,685
+13,954
+0.1% +$556K 0.03% 518
2021
Q3
$394M Buy
10,590,731
+22,345
+0.2% +$831K 0.03% 520
2021
Q2
$447M Buy
10,568,386
+20,038
+0.2% +$847K 0.04% 476
2021
Q1
$499M Buy
10,548,348
+334,493
+3% +$15.8M 0.04% 434
2020
Q4
$623M Buy
10,213,855
+79,879
+0.8% +$4.88M 0.06% 336
2020
Q3
$474M Buy
10,133,976
+3,439,232
+51% +$161M 0.05% 351
2020
Q2
$340M Buy
6,694,744
+1,816,519
+37% +$92.2M 0.04% 421
2020
Q1
$218M Buy
4,878,225
+2,455,383
+101% +$110M 0.03% 480
2019
Q4
$116M Sell
2,422,842
-29,740
-1% -$1.43M 0.01% 860
2019
Q3
$82.9M Buy
2,452,582
+78,140
+3% +$2.64M 0.01% 967
2019
Q2
$107M Sell
2,374,442
-62,293
-3% -$2.8M 0.01% 883
2019
Q1
$91.7M Sell
2,436,735
-365,782
-13% -$13.8M 0.01% 946
2018
Q4
$96.2M Buy
2,802,517
+36,729
+1% +$1.26M 0.01% 862
2018
Q3
$130M Buy
2,765,788
+1,462,534
+112% +$68.7M 0.01% 831
2018
Q2
$44M Buy
1,303,254
+187,900
+17% +$6.34M 0.01% 1339
2018
Q1
$30.2M Sell
1,115,354
-42,800
-4% -$1.16M ﹤0.01% 1528
2017
Q4
$19.3M Hold
1,158,154
﹤0.01% 1738
2017
Q3
$23.2M Buy
1,158,154
+454,181
+65% +$9.09M ﹤0.01% 1645
2017
Q2
$12.9M Buy
703,973
+27,500
+4% +$504K ﹤0.01% 1850
2017
Q1
$6.66M Sell
676,473
-55,571
-8% -$547K ﹤0.01% 2100
2016
Q4
$7.99M Buy
732,044
+481,556
+192% +$5.25M ﹤0.01% 2043
2016
Q3
$3.51M Sell
250,488
-885,723
-78% -$12.4M ﹤0.01% 2260
2016
Q2
$7.98M Sell
1,136,211
-225
-0% -$1.58K ﹤0.01% 2056
2016
Q1
$7.32M Sell
1,136,436
-793,591
-41% -$5.11M ﹤0.01% 2053
2015
Q4
$62.5M Buy
1,930,027
+482,214
+33% +$15.6M 0.01% 1175
2015
Q3
$38.7M Sell
1,447,813
-1,225,750
-46% -$32.7M 0.01% 1359
2015
Q2
$129M Sell
2,673,563
-2,379,773
-47% -$115M 0.02% 918
2015
Q1
$307M Buy
5,053,336
+12,955
+0.3% +$788K 0.04% 499
2014
Q4
$261M Buy
5,040,381
+580,004
+13% +$30M 0.03% 557
2014
Q3
$196M Sell
4,460,377
-50,790
-1% -$2.24M 0.03% 667
2014
Q2
$118M Sell
4,511,167
-348
-0% -$9.1K 0.02% 916
2014
Q1
$118M Buy
4,511,515
+2,434,297
+117% +$63.6M 0.02% 891
2013
Q4
$35.3M Buy
2,077,218
+562,200
+37% +$9.54M 0.01% 1483
2013
Q3
$32.5M Buy
+1,515,018
New +$32.5M 0.01% 1480